Varzideh Fahimeh, Kansakar Urna, Donkor Kwame, Wilson Scott, Jankauskas Stanislovas S, Mone Pasquale, Wang Xujun, Lombardi Angela, Santulli Gaetano
Department of Medicine, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research, New York, NY, United States.
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Wilf Family Cardiovascular Research Institute, Institute for Neuroimmunology and Inflammation (INI), New York, NY, United States.
Front Cardiovasc Med. 2022 Apr 13;9:863238. doi: 10.3389/fcvm.2022.863238. eCollection 2022.
After an ischemic injury, the heart undergoes a complex process of structural and functional remodeling that involves several steps, including inflammatory and fibrotic responses. In this review, we are focusing on the contribution of microRNAs in the regulation of inflammation and fibrosis after myocardial infarction. We summarize the most updated studies exploring the interactions between microRNAs and key regulators of inflammation and fibroblast activation and we discuss the recent discoveries, including clinical applications, in these rapidly advancing fields.
Front Cardiovasc Med. 2022-4-13
Cell Signal. 2021-1
Cell Tissue Res. 2016-9
J Cardiovasc Transl Res. 2010-3-30
J Cardiovasc Pharmacol. 2010-11
Biosci Rep. 2019-8-2
Sheng Li Xue Bao. 2017-10-25
Genes (Basel). 2025-3-27
Int J Mol Sci. 2024-12-29
J Mol Cell Cardiol. 2025-2
Noncoding RNA. 2024-10-23
J Lipid Atheroscler. 2024-9
Cardiovasc Diabetol. 2024-7-22
Cells. 2022-3-12
J Clin Invest. 2022-2-15
Front Cardiovasc Med. 2021-10-27
Front Cell Dev Biol. 2021-8-30
Noncoding RNA. 2021-7-7
Nat Rev Drug Discov. 2021-8
Front Cardiovasc Med. 2021-4-23